✦ LIBER ✦

Pharmacological characteristics of the stereoisomers of carvedilol

✍ Scribed by W. Bartsch; G. Sponer; K. Strein; B. Müller-Beckmann; L. Kling; E. Böhm; U. Martin; H. O. Borbe

Publisher: Springer
Year: 1990
Tongue: English
Weight: 318 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf01409475

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacology of carvedilol

✍ R. R. Ruffolo; M. Gellai; J. P. Hieble; R. N. Willette; A. J. Nichols 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 616 KB

Clinical pharmacology of carvedilol

✍ Tomlinson, B. ;Prichard, B.N.C. ;Graham, B.R. ;Walden, R.J. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 922 KB

Animal work has shown that carvedilol is a nonselective beta-blocking drug. It has a vasodilator action from alpha-receptor blockade, but there is evidence that it has further action to relax smooth muscle, possibly from calcium channel antagonism. Carvedilol is lipid soluble and 25% bioavailable, a

Clinical pharmacology of the stereoisome

Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing

✍ Richard L. Schilsky; Kyung E. Choi; Everett E. Vokes; Alfred Guaspari; Carol Gua 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

As part of a clinical trial of cisplatin, 5-fluorouracil (5-FU), and leucovorin (LV) for treatment of patients with advanced head and neck cancer, patients received 100 mg of LV (d,I-5-formyltetrahydrofolate) orally every 4 hours for 5 days. On days 2 and 4 of treatment, plasma samples were obtained

Synthesis and pharmacological evaluation

Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid

✍ Renuka Gupte; Anjaih Siddam; Yan Lu; Wei Li; Yuko Fujiwara; Nattapon Panupinthu; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 395 KB

Cyclic phosphatidic acid (CPA) is a naturally occurring analog of lysophosphatidic acid (LPA) in which the sn-2 hydroxy group forms a five-membered ring with the sn-3 phosphate. Here, we describe the synthesis of R-3-CCPA and S-3-CCPA along with their pharmacological properties as inhibitors of lyso

Effects of carvedilol on adrenergic rece

Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes

✍ Bristow, M.R. ;Larrabee, P. ;M�ller-Beckmann, B. ;Minobe, W. ;Roden, R. ;Skerl, 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 778 KB

Carvedilol, a new beta-blocker with vasodilating properties due to alpha 1-blockade, was investigated in preparations of human ventricular myocardium. Carvedilol demonstrated a high affinity and is a slightly beta 1-selective competitive beta-blocking agent, with a KD for beta 1-receptors of approxi

Pharmacological profile of ?-adrenocepto

Pharmacological profile of ?-adrenoceptor blockers with vasodilating properties, especially carvedilol ? rationale for clinical use

✍ Sponer, G. ;Bartsch, W. ;Strem, K. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 750 KB

The rationale for the combined use of beta-adrenoceptor antagonists and vasodilators is to improve the efficacy of the antihypertensive therapy and to reduce the incidence of side effects. If suitable coagents are selected and used at appropriate doses, the disadvantages of each separate component (